{"DataElement":{"publicId":"2002502","version":"3","preferredName":"Disease Relapse Progression Ind-3","preferredDefinition":"the yes/no/unknown indicator that asks whether there was a first relapse or progression of disease.","longName":"DZ_REL_PROG_IND3","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195593","version":"1","preferredName":"Disease Recurrent Disease Cancer Progression Diagnosis","preferredDefinition":"information related to the diagnosis of the return of signs and symptoms of cancer after a period of improvement or an increase in the size of a tumor or spread of cancer in the body.","longName":"DZ_RECUR_PROG_DX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2748435","version":"1","preferredName":"Recurrent Disease Cancer Progression Diagnosis","preferredDefinition":"the return of a sign, symptom, or disease after a remission.:The worsening of a cancer over time.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C38155:C19987:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cancer Progression","conceptCode":"C19987","definition":"A pathologic process in which alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4CA6D9C5-F8C0-22FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-05-07","modifiedBy":"ONEDATA","dateModified":"2008-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED9048B9-AB75-5C83-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506034","version":"1","preferredName":"Yes No Unknown Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.","longName":"YES_NO_UNKNOWN_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D05-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D0F-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3241403","version":"1","preferredName":"Unknown","longName":"3241403","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A3A-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"MMADDINENI","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D1A-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2548260","version":"1","preferredName":"Ind-3","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no/unknown.","longName":"C38148","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, or Unknown Response","conceptCode":"C38148","definition":"A response or indicator that can have a value of yes, no, or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"23801A33-5B13-534B-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2006-11-30","endDate":"2016-04-27","createdBy":"BIRNBAUA","dateCreated":"2006-11-30","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 4-27-2016 per Tina Taylor approved by Dianne Reeves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C379D9D0-6CF1-CCDD-E040-BB89AD432590","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TITARENI","dateModified":"2021-09-14","changeDescription":"3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 3/35/2016 jk removed \"indeterminate\" value that was added in error. 7/7/2021wz: added ALT VM name for HOPE-CARE project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811955","version":"1","longName":"Follow-up","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"2964591","version":"1","longName":"Eligibility Criteria","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2965104","version":"1","longName":"Structured Eligibility Criteria","context":"NCIP"},{"publicId":"3070842","version":"1","longName":"Diagnosis","context":"NCIP"}]},{"publicId":"3234177","version":"1","longName":"Patient Outcomes Data System (PODS)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3234178","version":"1","longName":"PODS Elements","context":"NCIP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104890","version":"1","longName":"GOG-0229L","context":"NRG"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"PtRelapseThisRptPeriod","type":"COG Form Element","context":"CTEP"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"PRGREL","type":"OID, SWOG","context":"SWOG"},{"name":"DZ_REL_PROG_IND3","type":"USED_BY","context":"AECC"},{"name":"DZ_REL_PROG_IND3","type":"USED_BY","context":"Alliance"},{"name":"DZ_REL_PROG_IND3","type":"USED_BY","context":"CTEP"},{"name":"DZ_REL_PROG_IND3","type":"USED_BY","context":"SWOG"},{"name":"DZ_REL_PROG_IND3","type":"USED_BY","context":"NRG"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"DZ_REL_PROG_IND3","type":"USED_BY","context":"OHSU Knight"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"RS_RSORRES_LOCALIND","type":"OID, CCTG","context":"CCTG"},{"name":"RS_RSSTAT_RPD","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Has the patient developed a f","type":"Preferred Question Text","description":"Has the patient developed a first relapse or progression that has not been previously reported","url":null,"context":"CTEP"},{"name":"1-COMMENT","type":"COMMENT","description":"This question was requested specifically by SWOG.","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Has the patient progressed or relapsed","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Has the patient been diagnosed with relapsed/recurrent or progressive disease","url":null,"context":"CTEP"},{"name":"Outcome Measures CRF Question Text","type":"Alternate Question Text","description":"Disease Progression in current period?","url":null,"context":"NCIP"},{"name":"OHSU Text 1","type":"Alternate Question Text","description":"Disease status - Progression/Relapse?","url":null,"context":"OHSU Knight"},{"name":"AECC Text","type":"Alternate Question Text","description":"Did patient first experience disease progression during this reporting period?","url":null,"context":"AECC"},{"name":"Has the patient progressed or relapsed?","type":"Alternate Question Text","description":"Has the patient progressed or relapsed (per the definition in Section 10.0 of the protocol)?","url":null,"context":"SWOG"},{"name":"Has the patient developed a f","type":"Alternate Question Text","description":"Has the patient developed a first relapse or progression that has not been previously reported?","url":null,"context":"SWOG"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Has the patient developed a first soft tissue relapse/progression or confirmed bone progression that has not been previously reported?","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Has the patient developed a first unequivocal progression that has not been previously reported?","url":null,"context":"CTEP"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Has the patient developed a first relapse that has not been previously reported?","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Is patient diagnosed with first relapse of B-Lymphoblastic Leukemia (B-ALL) with or without extramedullary disease?","url":null,"context":"COG"},{"name":"COG CRF TEXT 3","type":"Alternate Question Text","description":"Did the patient develop a first relapse that has not been previously reported?","url":null,"context":"COG"},{"name":"COG CRF TEXT 4","type":"Alternate Question Text","description":"Did the patient develop a first progression or relapse that has not been previously reported?","url":null,"context":"COG"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Has the patient developed a relapse/progression that has not been previously reported?","url":null,"context":"CTEP"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Has the patient developed a first relapse/progression that has not been previously reported?","url":null,"context":"CTEP"},{"name":"COG CRF Text 7","type":"Alternate Question Text","description":"Is patient in first relapse?","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Has the patient developed a confirmed progression that has not been previously reported?","url":null,"context":"CTEP"},{"name":"COG CRF Text 9","type":"Alternate Question Text","description":"Has the patient developed a first relapse or progression that has not been previously reported?","url":null,"context":"CTEP"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"Has the patient developed a relapse that has not been previously reported?","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Has the patient developed an invasive progression or recurrence that has not been previously reported?","url":null,"context":"Alliance"},{"name":"CRF Text6","type":"Alternate Question Text","description":"First invasive local regional or distant recurrence?","url":null,"context":"Alliance"},{"name":"COG CRF Text 11","type":"Alternate Question Text","description":"Is patient diagnosed with first relapse of B-Lymphoblastic Leukemia (B-ALL)?","url":null,"context":"COG"},{"name":"CRF Text7","type":"Alternate Question Text","description":"did the patient have an initial progression not previously reported?","url":null,"context":"Alliance"},{"name":"COG CRF Text 10","type":"Alternate Question Text","description":"Did patient relapse/progress during this reporting period?","url":null,"context":"COG"},{"name":"COG CRF Text 12","type":"Alternate Question Text","description":"Has patient developed a first relapse that has not been previously reported?","url":null,"context":"COG"},{"name":"COG CRF Text 14","type":"Alternate Question Text","description":"Is this the first relapse/progression after study enrollment?","url":null,"context":"COG"},{"name":"COG CRF Text 13","type":"Alternate Question Text","description":"Did patient develop a first relapse/progression after enrollment that has not been previously reported?","url":null,"context":"COG"},{"name":"COG CRF 17","type":"Alternate Question Text","description":"Is patient in first marrow relapse?","url":null,"context":"COG"},{"name":"COG CRF Text 15","type":"Alternate Question Text","description":"Did patient relapse during this reporting period?","url":null,"context":"COG"},{"name":"COG CRF Text 16","type":"Alternate Question Text","description":"Has the patient developed a first relapse or progression after start of Induction Cycle 3 that has not been previously reported?","url":null,"context":"COG"},{"name":"COG CRF Text 18","type":"Alternate Question Text","description":"Did patient experience disease progression/relapse during this reporting period?","url":null,"context":"COG"},{"name":"CRF Text10","type":"Alternate Question Text","description":"has the patient developed a first confirmed relapse or progression that has not been previously reported?","url":null,"context":"Alliance"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Has the patient had a local-regional recurrence or distant metastasis of this disease?","url":null,"context":"Alliance"},{"name":"CRF Text9","type":"Alternate Question Text","description":"has the patient developed a first recurrence or progression that has not been previously reported?","url":null,"context":"Alliance"},{"name":"CCTG - 1","type":"Alternate Question Text","description":"Did the patient relapse/progress during this reporting period (extracranial disease)?","url":null,"context":"CCTG"},{"name":"CRF Text 19","type":"Alternate Question Text","description":"Has the patient been diagnosed with first regional recurrence?","url":null,"context":"NRG"},{"name":"COG CRF TEXT 10","type":"Alternate Question Text","description":"Did patient develop first relapse during this observation period?","url":null,"context":"COG"},{"name":"COG CRF TEXT 19","type":"Alternate Question Text","description":"Did patient develop first relapse during this observation period?","url":null,"context":"COG"},{"name":"CRF Text11","type":"Alternate Question Text","description":"Did the patient have progression during this reporting period?","url":null,"context":"Alliance"},{"name":"CRF Text12","type":"Alternate Question Text","description":"has the patient developed a first relapse or progression  that has not been previously reported?","url":null,"context":"Alliance"},{"name":"COG CRF TEXT 20","type":"Alternate Question Text","description":"Did the patient's disease progress or relapse during the indicated period","url":null,"context":"COG"},{"name":"CRF Text13","type":"Alternate Question Text","description":"Has the patient developed a relapse or progression during this reporting period?","url":null,"context":"Alliance"},{"name":"COG CRF Text 01","type":"Alternate Question Text","description":"Has the patient developed a FIRST relapse or progression that has not been previously reported?","url":null,"context":"COG"},{"name":"COG CRF Text 28","type":"Alternate Question Text","description":"Is patient diagnosed with first relapse of CD19+ B-ALL (relapse blasts must express CD19)?","url":null,"context":"COG"},{"name":"Has the patient developed first post study enrollment relapse or progression that has not been previously reported?","type":"Alternate Question Text","description":"Has the patient developed first post study enrollment relapse or progression that has not been previously reported?","url":null,"context":"COG"},{"name":"Did the patient develop a first progression or relapse while receiving crossover therapy that has not previously been reported?","type":"Alternate Question Text","description":"Did the patient develop a first progression or relapse while receiving crossover therapy that has not previously been reported?","url":null,"context":"COG"},{"name":"NRG CRF Text 3","type":"Alternate Question Text","description":"Has there been progression within 12 months after completion of the regimen?","url":null,"context":"NRG"},{"name":"COG CRF TEXT 21","type":"Alternate Question Text","description":"Did the patient relapse during this reporting period?","url":null,"context":"COG"},{"name":"NRG CRF Text 2","type":"Alternate Question Text","description":"If yes, Has there been progression within 12 months after completion of the regimen?","url":null,"context":"NRG"},{"name":"CCTG - 2","type":"Alternate Question Text","description":"Does the patient have local recurrence or progression?","url":null,"context":"CCTG"},{"name":"COG CRF Text 17","type":"Alternate Question Text","description":"Did the patient develop a first progression or relapse in an eye that has not been previously reported?","url":null,"context":"COG"},{"name":"COG CRF Text 22","type":"Alternate Question Text","description":"Did the patient develop a first progression or relapse in an eye that has not been previously reported?","url":null,"context":"COG"}],"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A36167C1-BCA0-15C7-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2005-04-22","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-06-14","modifiedBy":"CLOHNES","dateModified":"2023-02-23","changeDescription":"Replaced VD Disease Ind-3 (2018305v1) with VD Yes No Unknown Indicator (3506034v1) - dw","administrativeNotes":"2/23/23 added CCTG alt OID for ticket number CADSR0002081 cjl; 6/16/22 add AQT and alt OID, CCTG for Chad Winch CCTG cjl 2022.9.16 AQ T added per email. ak","unresolvedIssues":null,"deletedIndicator":"No"}}